| Canagliflozin prevents diabetes-induced vascular dysfunction in ApoE-deficient mice A Rahadian, D Fukuda, HM Salim, S Yagi, K Kusunose, H Yamada, ... Journal of Atherosclerosis and Thrombosis 27 (11), 1141-1151, 2020 | 57 | 2020 |
| Thrombin inhibition by dabigatran attenuates endothelial dysfunction in diabetic mice A Rahadian, D Fukuda, HM Salim, S Yagi, K Kusunose, H Yamada, ... Vascular Pharmacology 124, 106632, 2020 | 25 | 2020 |
| Olive mill wastewater and hydroxytyrosol inhibits atherogenesis in apolipoprotein E-deficient mice T Hara, D Fukuda, B Ganbaatar, PT Pham, K Aini, A Rahadian, K Suto, ... Heart and Vessels 38 (11), 1386-1394, 2023 | 2 | 2023 |
| P722 Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice A Rahadian, D Fukuda, H Salim, S Yagi, K Kusunose, H Yamada, T Soeki, ... European Heart Journal 40 (Supplement_1), ehz747. 0327, 2019 | 1 | 2019 |
| Glycemic control with canagliflozin, a SGLT-2 inhibitor, attenuates atherosclerosis and endothelial dysfunction in diabetic apolipoprotein e-deficient mice A Rahadian, D Fukuda, H Salim, S Yagi, K Kusunose, H Yamada, T Soeki, ... EUROPEAN HEART JOURNAL 40, 329-329, 2019 | | 2019 |
